Distribution of participating centres by proportion of subjects to whom purified protein derivative (PPD) screening was offered and who completed PPD screening
| Characteristics of centres | PPD screening offer | PPD screening completion | ||||
| <95% | >95% | p-value | <95% | ≥95% | p-value | |
| Centres offering PPD screening n | 8 | 20 | 22 | 6 | ||
| Number of AIDS cases reported during the enrolment period | ||||||
| ⪕100 | 1(7.1) | 13(92.9) | 11(78.6) | 3 21.4 | ||
| >100 | 7(50.0) | 7(50.0) | 0.03 | 11(78.6) | 3 21.4 | ns |
| Geographical location in Italy | ||||||
| North | 5(33.3) | 10(66.7) | 11(73.3) | 4(26.7) | ||
| Central | 1(14.3) | 6(85.7) | 7(100.0) | 0(0.0) | ||
| South | 2(33.3) | 4(66.7) | ns | 4(66.7) | 2(33.3) | ns |
| Hospital | ||||||
| Non-teaching | 6(30.0) | 14(25.0) | 15(75.0) | 5(25.0) | ||
| Teaching | 2(70.0) | 6(75.0) | ns | 7(87.5) | 1(12.5) | ns |
Data are presented as n (%) unless ofherwise stated
AIDS: acquired immune deficiency syndrome
ns: nonsignificart